Suppr超能文献

LAN血型系统综述

The LAN blood group system:a review.

作者信息

Peyrard Thierry

机构信息

PharmD, PhD, European Specialist in Clinical Chemistry and Laboratory Medicine (EurClinChem), Head of the National Immunohematology Reference Laboratory (CNRGS), National Institute of Blood Transfusion (INTS), 20 rue Bouvier, 75011 Paris, France.

出版信息

Immunohematology. 2013;29(4):131-5.

Abstract

LAN (Langereis) was officially recognized by the International Society of Blood Transfusion in 2012 as being the 33rd human blood group system. It consists of one single high-prevalence antigen,Lan (LANl). The ABCB6 protein is the carrier of the Lan blood group antigen. The ABCB6 gene (chromosome 2q36, 19 exons)encodes the ABCB6 polypeptide (ATP-binding cassette protein,subfamily B, member 6), known as a porphyrin transporter.The exceptional Lan- people do not express ABCB6 (Lan null phenotype), owing to several different molecular mechanisms affecting ABCB6: frameshift leading to a premature stop codon(deletion, insertion, or nonsense mutation of nucleotides);missense mutation; or intronic mutation responsible for RNA splicing defect. Despite the Lan antigen's being reported to play a key role in erythropoiesis and detoxification of cells, Lan people do not appear to demonstrate susceptibility to any disease or seemingly physiologic disorder. Anti-Lan has been described as having variable clinical significance, either for hemolytic transfusion reactions (none to severe) or hemolytic disease of the fetus and newborn (none to mild). Despite challenging conditions caused by the scarcity of Lan- donors worldwide, Lan- blood should ideally be given to patients with anti-Lan, especially those with a high-titer antibody.

摘要

LAN(朗格赖斯)于2012年被国际输血协会正式认可为第33个人类血型系统。它由一种单一的高频率抗原Lan(LAN1)组成。ABCB6蛋白是Lan血型抗原的载体。ABCB6基因(位于2号染色体q36,含19个外显子)编码ABCB6多肽(ATP结合盒蛋白,B亚家族,成员6),即一种卟啉转运蛋白。由于影响ABCB6的几种不同分子机制,罕见的Lan阴性个体不表达ABCB6(Lan null表型):移码导致提前终止密码子(核苷酸的缺失、插入或无义突变);错义突变;或导致RNA剪接缺陷的内含子突变。尽管据报道Lan抗原在红细胞生成和细胞解毒中起关键作用,但Lan阴性个体似乎对任何疾病或明显的生理紊乱都没有易感性。抗-Lan被描述为具有不同的临床意义,无论是对于溶血性输血反应(从无到严重)还是胎儿及新生儿溶血病(从无到轻度)。尽管全球Lan阴性献血者稀缺带来了挑战,但理想情况下,应将Lan阴性血液输给有抗-Lan的患者,尤其是那些抗体效价高的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验